Myelofibrosis history and symptoms: Difference between revisions
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
===History=== | ===History=== | ||
Patients with myelofibrosis may have a positive history of: | Patients with myelofibrosis may have a positive history of: | ||
*Fatigue (the most commonly reported)<ref name="pmid24403262">{{cite journal |vauthors=Mitra D, Kaye JA, Piecoro LT, Brown J, Reith K, Mughal TI, Sarlis NJ |title=Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review |journal=Cancer Med |volume=2 |issue=6 |pages=889–98 |date=December 2013 |pmid=24403262 |pmc=3892393 |doi=10.1002/cam4.136 |url=}}</ref> | *Fatigue (the most commonly reported)<ref name="pmid30472746">{{cite journal |vauthors=Birgegard G, Samuelsson J, Ahlstrand E, Ejerblad E, Enevold C, Ghanima W, Hasselbalch H, Nielsen CH, Knutsen H, Pedersen OB, Sørensen A, Andreasson B |title=Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group |journal=Eur. J. Haematol. |volume= |issue= |pages= |date=November 2018 |pmid=30472746 |doi=10.1111/ejh.13198 |url=}}</ref><ref name="pmid30100963">{{cite journal |vauthors=Chahdi H, Oukabli M |title=[A special form of pancytopenia] |language=French |journal=Pan Afr Med J |volume=29 |issue= |pages=209 |date=2018 |pmid=30100963 |pmc=6080970 |doi=10.11604/pamj.2018.29.209.14055 |url=}}</ref><ref name="pmid30039550">{{cite journal |vauthors=Tefferi A |title=Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management |journal=Am. J. Hematol. |volume=93 |issue=12 |pages=1551–1560 |date=December 2018 |pmid=30039550 |doi=10.1002/ajh.25230 |url=}}</ref> | ||
*Weight loss | *Night sweats<ref name="Tefferi2000">{{cite journal|last1=Tefferi|first1=Ayalew|title=Myelofibrosis with Myeloid Metaplasia|journal=New England Journal of Medicine|volume=342|issue=17|year=2000|pages=1255–1265|issn=0028-4793|doi=10.1056/NEJM200004273421706}}</ref> | ||
*Bone pain<ref name="pmid28544906">{{cite journal |vauthors=Gwaltney C, Paty J, Kwitkowski VE, Mesa RA, Dueck AC, Papadopoulos EJ, Wang L, Feliciano J, Coons SJ |title=Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials |journal=Leuk. Res. |volume=59 |issue= |pages=26–31 |date=August 2017 |pmid=28544906 |doi=10.1016/j.leukres.2017.05.012 |url=}}</ref> | |||
*Fever<ref name="pmid24403262">{{cite journal |vauthors=Mitra D, Kaye JA, Piecoro LT, Brown J, Reith K, Mughal TI, Sarlis NJ |title=Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review |journal=Cancer Med |volume=2 |issue=6 |pages=889–98 |date=December 2013 |pmid=24403262 |pmc=3892393 |doi=10.1002/cam4.136 |url=}}</ref><ref name="pmid23684482">{{cite journal |vauthors=Mesa RA, Shields A, Hare T, Erickson-Viitanen S, Sun W, Sarlis NJ, Sandor V, Levy RS, Verstovsek S |title=Progressive burden of myelofibrosis in untreated patients: assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study |journal=Leuk. Res. |volume=37 |issue=8 |pages=911–6 |date=August 2013 |pmid=23684482 |doi=10.1016/j.leukres.2013.04.017 |url=}}</ref> | |||
*Generalized abdominal pain | *Weight loss<ref name="Tefferi2000">{{cite journal|last1=Tefferi|first1=Ayalew|title=Myelofibrosis with Myeloid Metaplasia|journal=New England Journal of Medicine|volume=342|issue=17|year=2000|pages=1255–1265|issn=0028-4793|doi=10.1056/NEJM200004273421706}}</ref> | ||
*Generalized abdominal pain<ref name="pmid27521149">{{cite journal |vauthors=Pizzi M, Gergis U, Chaviano F, Orazi A |title=The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis |journal=Hematol Oncol Stem Cell Ther |volume=9 |issue=3 |pages=96–104 |date=September 2016 |pmid=27521149 |doi=10.1016/j.hemonc.2016.07.002 |url=}}</ref><ref name="pmid26885416">{{cite journal |vauthors=Mohyuddin GR, Yacoub A |title=Primary Myelofibrosis Presenting as Extramedullary Hematopoiesis in a Transplanted Liver Graft: Case Report and Review of the Literature |journal=Case Rep Hematol |volume=2016 |issue= |pages=9515404 |date=2016 |pmid=26885416 |pmc=4739215 |doi=10.1155/2016/9515404 |url=}}</ref> | |||
*Left subcostal pain | *Left subcostal pain | ||
*Early satiety | *Early satiety | ||
Revision as of 18:46, 3 December 2018
|
Myelofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myelofibrosis history and symptoms On the Web |
|
American Roentgen Ray Society Images of Myelofibrosis history and symptoms |
|
Risk calculators and risk factors for Myelofibrosis history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
A significant proportion of patients with myelofibrosis can be asymptomatic. The hallmark of the disease is pancytopenia. A positive history of fatigue, recurring infections, and bleeding complications is suggestive of myelofibrosis. The most common symptom is fatigue which is prominent enough as it remarkably affects the quality of life. Fatigue, a result of anemia, leads to the associated complaints of weakness, palpitations, and dyspnea on exertion. Other nonspecific symptoms such as fever, night sweats, and weight loss can also be present at diagnosis.
History and Symptoms
History
Patients with myelofibrosis may have a positive history of:
- Fatigue (the most commonly reported)[1][2][3]
- Night sweats[4]
- Bone pain[5]
- Fever[6][7]
- Weight loss[4]
- Generalized abdominal pain[8][9]
- Left subcostal pain
- Early satiety
Symptoms of myelofibrosis include:[10][11][12]
- Left upper quadrant abdominal pain
- Bruising
- Easy bleeding
- Pale skin
- Frequent infections
- Fatigue
- Loss of appetite
- Weight loss
- Fever
- Night sweats
- Shortness of breath with exercise
- Skin nodules, in a variant known as cutaneous myelofibrosis
References
- ↑ Birgegard G, Samuelsson J, Ahlstrand E, Ejerblad E, Enevold C, Ghanima W, Hasselbalch H, Nielsen CH, Knutsen H, Pedersen OB, Sørensen A, Andreasson B (November 2018). "Inflammatory functional iron deficiency common in myelofibrosis, contributes to anaemia and impairs quality of life. From the Nordic MPN study Group". Eur. J. Haematol. doi:10.1111/ejh.13198. PMID 30472746.
- ↑ Chahdi H, Oukabli M (2018). "[A special form of pancytopenia]". Pan Afr Med J (in French). 29: 209. doi:10.11604/pamj.2018.29.209.14055. PMC 6080970. PMID 30100963.
- ↑ Tefferi A (December 2018). "Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management". Am. J. Hematol. 93 (12): 1551–1560. doi:10.1002/ajh.25230. PMID 30039550.
- ↑ 4.0 4.1 Tefferi, Ayalew (2000). "Myelofibrosis with Myeloid Metaplasia". New England Journal of Medicine. 342 (17): 1255–1265. doi:10.1056/NEJM200004273421706. ISSN 0028-4793.
- ↑ Gwaltney C, Paty J, Kwitkowski VE, Mesa RA, Dueck AC, Papadopoulos EJ, Wang L, Feliciano J, Coons SJ (August 2017). "Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials". Leuk. Res. 59: 26–31. doi:10.1016/j.leukres.2017.05.012. PMID 28544906.
- ↑ Mitra D, Kaye JA, Piecoro LT, Brown J, Reith K, Mughal TI, Sarlis NJ (December 2013). "Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review". Cancer Med. 2 (6): 889–98. doi:10.1002/cam4.136. PMC 3892393. PMID 24403262.
- ↑ Mesa RA, Shields A, Hare T, Erickson-Viitanen S, Sun W, Sarlis NJ, Sandor V, Levy RS, Verstovsek S (August 2013). "Progressive burden of myelofibrosis in untreated patients: assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study". Leuk. Res. 37 (8): 911–6. doi:10.1016/j.leukres.2013.04.017. PMID 23684482.
- ↑ Pizzi M, Gergis U, Chaviano F, Orazi A (September 2016). "The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis". Hematol Oncol Stem Cell Ther. 9 (3): 96–104. doi:10.1016/j.hemonc.2016.07.002. PMID 27521149.
- ↑ Mohyuddin GR, Yacoub A (2016). "Primary Myelofibrosis Presenting as Extramedullary Hematopoiesis in a Transplanted Liver Graft: Case Report and Review of the Literature". Case Rep Hematol. 2016: 9515404. doi:10.1155/2016/9515404. PMC 4739215. PMID 26885416.
- ↑ Symptoms of myelofibrosis. US National Library of Medicine 2016. https://www.nlm.nih.gov/medlineplus/ency/article/000531.htm. Accessed on March 7, 2016
- ↑ Symptoms of idiopathic myelofibrosis. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/idiopathic-myelofibrosis/?region=on. Accessed on March 9, 2016
- ↑ Symptoms of primary myelofibrosis include pain below the ribs on the left side and feeling very tired. National cancer institute 2016. http://www.cancer.gov/types/myeloproliferative/patient/chronic-treatment-pdq#section/_234. Accessed on March 10, 2016